Skip to main content
SpringerLink
Log in

Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma

  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

Methods

We examined the expression of mucin core protein 1 (MUC1) immunohistochemically in 186 surgical specimens of histopathologically nonmucinous hepatocellular carcinoma (HCC) and compared the clinicopathological features in patients with MUC1-positive HCC (MUC1-positive group) with those in patients with MUC1-negative HCC (MUC1-negative group).

Results

MUC1 immunoreactively was present in 85 of the 186 HCCs. Of the clinicopathological variables examined, the serum concentration of α-fetoprotein, tumor differentiation, bile duct invasion, lymph node metastasis, and cytokeratin 19 expression exhibited significant associations with MUC1 expression. Although cumulative and tumor-free survival rates were not different between the two groups, the percentage of patients with first recurrence of HCC in distant organs (distant metastasis) within 2 years after surgery was significantly higher in the MUC1-positive group than in the MUC1-negative group (P = 0.0104). The risk ratio of MUC1 positivity for this type of distant metastasis was 3.156 (95% confidence interval, 1.064–9.358).

Conclusions

In patients with MUC1-positive HCC, careful follow-up is necessary, not only for intrahepatic recurrence but also for distant metastasis, after the resection of primary HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. T Uenishi S Kubo K Hirohashi T Yamamoto M Ogawa H Tanaka et al. (2002) ArticleTitleExpression of bile duct-type cytokeratin in hepatocellular carcinoma in patients with hepatitis C virus and prior hepatitis B virus infection Cancer Lett 178 107–12 Occurrence Handle11849748 Occurrence Handle1:CAS:528:DC%2BD38Xht1ahtrg%3D Occurrence Handle10.1016/S0304-3835(01)00813-8

    Article  PubMed  CAS  Google Scholar 

  2. T Uenishi S Kubo T Yamamoto T Shuto M Ogawa H Tanaka et al. (2003) ArticleTitleCytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence Cancer Sci 94 851–7 Occurrence Handle14556657 Occurrence Handle1:CAS:528:DC%2BD3sXpsFGhtL4%3D Occurrence Handle10.1111/j.1349-7006.2003.tb01366.x

    Article  PubMed  CAS  Google Scholar 

  3. M Osborn G van Lessen K Weber G Kloppel M Altmannsberger (1986) ArticleTitleDifferential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides Lab Invest 55 497–504 Occurrence Handle2429069 Occurrence Handle1:STN:280:DyaL2s%2FhtlSqtQ%3D%3D

    PubMed  CAS  Google Scholar 

  4. YS Lai SN Thung MA Gerber ML Chen F Schaffner (1989) ArticleTitleExpression of cytokeratins in normal and diseased livers and in primary liver carcinomas Arch Pathol Lab Med 113 134–8 Occurrence Handle2464975 Occurrence Handle1:STN:280:DyaL1M7jtlOhtw%3D%3D

    PubMed  CAS  Google Scholar 

  5. AJ Balaton M Nehama-Sibony C Gotheil P Callard EE Baviera (1988) ArticleTitleDistinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections J Pathol 156 305–10 Occurrence Handle2465399 Occurrence Handle1:STN:280:DyaL1M7ktFamtw%3D%3D Occurrence Handle10.1002/path.1711560405

    Article  PubMed  CAS  Google Scholar 

  6. DE Johnson BG Herndier LJ Medeiros RA Warnke RV Rouse (1988) ArticleTitleThe dianostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma Am J Surg Pathol 12 187–97 Occurrence Handle2449824 Occurrence Handle1:STN:280:DyaL1c7kvVajsg%3D%3D Occurrence Handle10.1097/00000478-198803000-00004

    Article  PubMed  CAS  Google Scholar 

  7. AS Leong RT Sormunen WM Tsui Liew CT. Hep (1998) ArticleTitlePar 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma Histopathology 33 318–24 Occurrence Handle9822920 Occurrence Handle1:STN:280:DyaK1M%2FktVamtg%3D%3D Occurrence Handle10.1046/j.1365-2559.1998.00522.x

    Article  PubMed  CAS  Google Scholar 

  8. P Van Eyken R Sciot A Paterson F Callea MC Kew VJ Desmet (1988) ArticleTitleCytokeratin expression in hepatocellular carcinoma: an immunohistochemical study Hum Pathol 19 562–8 Occurrence Handle2453442 Occurrence Handle1:STN:280:DyaL1c3is1KhtQ%3D%3D

    PubMed  CAS  Google Scholar 

  9. HP Fischer M Aeltmannsberger K Weber M Osborn (1987) ArticleTitleKeratin polypeptides in malignant epithelial liver tumors. Differerntial diagnostic and histogenetic aspects Am J Pathol 127 530–7 Occurrence Handle2438941 Occurrence Handle1:STN:280:DyaL2s3jvVyntQ%3D%3D

    PubMed  CAS  Google Scholar 

  10. PC Wu JW Fang VK Lau CL Lai CK Lo JY Lau (1996) ArticleTitleClassification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications Am J Pathol 149 1167–75 Occurrence Handle8863666 Occurrence Handle1:STN:280:DyaK2s%2FhslSmsQ%3D%3D

    PubMed  CAS  Google Scholar 

  11. SJ Gendler CA Lancaster J Taylor-Papadimitriou T Duhig N Peat J Burchell et al. (1990) ArticleTitleMolecular cloning and expression of human tumor-associated polymorphic epithelial mucin J Biol Chem 265 15286–93 Occurrence Handle1697589 Occurrence Handle1:CAS:528:DyaK3MXlslKktA%3D%3D

    PubMed  CAS  Google Scholar 

  12. JR Gum SuffixJr (1995) ArticleTitleHuman mucin glycoproteins: varied structures predict diverse properties and specific functions Biochem Soc Trans 23 795–9 Occurrence Handle8654840 Occurrence Handle1:CAS:528:DyaK28XhtVWlsr4%3D

    PubMed  CAS  Google Scholar 

  13. SB Ho YS Kim (1991) ArticleTitleCarbohydrate antigens on cancer-associated mucin-like molecules Semin Cancer Biol 2 389–400 Occurrence Handle1725730 Occurrence Handle1:CAS:528:DyaK3sXlsFOktLc%3D

    PubMed  CAS  Google Scholar 

  14. SB Ho GA Niehans C Lyftogt PS Yan DL Cherwitz ET Gum et al. (1993) ArticleTitleHeterogeneity of mucin gene expression in normal and neoplastic tissues Cancer Res 53 641–51 Occurrence Handle7678777 Occurrence Handle1:CAS:528:DyaK3sXhsVClu7g%3D

    PubMed  CAS  Google Scholar 

  15. Y Cao U Karsten G Otto P Bannasch (1999) ArticleTitleExpression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha 2, 6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions Virchows Arch 434 503–9 Occurrence Handle10394884 Occurrence Handle1:CAS:528:DyaK1MXjtlektLw%3D Occurrence Handle10.1007/s004280050375

    Article  PubMed  CAS  Google Scholar 

  16. YS Kim J Gum SuffixJr I Brockhausen (1996) ArticleTitleMucin glycoproteins in neoplasia Glycoconj J 13 693–707 Occurrence Handle8909996 Occurrence Handle1:CAS:528:DyaK28XmslCls7Y%3D Occurrence Handle10.1007/BF00702333

    Article  PubMed  CAS  Google Scholar 

  17. S Yonezawa E Sato (1997) ArticleTitleExpression of mucin antigens in human cancers and its relationship with malignancy potential Pathol Int 47 813–30 Occurrence Handle9503463 Occurrence Handle1:CAS:528:DyaK1cXhsVGrtLg%3D Occurrence Handle10.1111/j.1440-1827.1997.tb03713.x

    Article  PubMed  CAS  Google Scholar 

  18. S Yonezawa A Nakamura M Horinouchi E Sato (2002) ArticleTitleThe expression of several types of mucin is related to the biological behavior of pancreatic neoplasms J Hepatobiliary Pancreat Surg 9 328–41 Occurrence Handle12353144 Occurrence Handle10.1007/s005340200037

    Article  PubMed  Google Scholar 

  19. M Sasaki Y Nakanuma (1994) ArticleTitleExpression of mucin core protein of mammary type in primary liver cancer Hepatology 20 1192–7 Occurrence Handle7523272 Occurrence Handle1:STN:280:DyaK2M%2Fht1WgsQ%3D%3D Occurrence Handle10.1016/0270-9139(94)90756-0

    Article  PubMed  CAS  Google Scholar 

  20. T Utsunomiya S Yonezawa H Sakamoto H Kitamura S Hokita T Aiko et al. (1998) ArticleTitleExpression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients Clin Cancer Res 4 2605–14 Occurrence Handle9829723 Occurrence Handle1:STN:280:DyaK1M%2FksFWrug%3D%3D

    PubMed  CAS  Google Scholar 

  21. S Nakamori DM Ota KR Cleary K Shirotani T Irimura (1994) ArticleTitleMUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma Gastroenterology 106 353–61 Occurrence Handle7905449 Occurrence Handle1:STN:280:DyaK2c7jtFagsg%3D%3D

    PubMed  CAS  Google Scholar 

  22. S Takao K Uchikura S Yonezawa H Shinchi T Aikou (1999) ArticleTitleMucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis Cancer 86 1966–75 Occurrence Handle10570420 Occurrence Handle1:CAS:528:DyaK1MXotVOgtr8%3D Occurrence Handle10.1002/(SICI)1097-0142(19991115)86:10<1966::AID-CNCR13>3.0.CO;2-M

    Article  PubMed  CAS  Google Scholar 

  23. S Tamada M Goto M Nomoto K Nagata T Shimizu S Tanaka et al. (2002) ArticleTitleExpression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis Pathol Int 52 713–23 Occurrence Handle12685548 Occurrence Handle10.1046/j.1440-1827.2002.01414.x

    Article  PubMed  Google Scholar 

  24. K Yamashita S Yonezawa S Tanaka H Shirahama K Sakoda K Imai et al. (1993) ArticleTitleImmunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma Int J Cancer 55 82–91 Occurrence Handle8393843 Occurrence Handle1:STN:280:DyaK3szks1Whtw%3D%3D

    PubMed  CAS  Google Scholar 

  25. N Matsumura M Yamamoto A Aruga K Takasaki M Nakano (2002) ArticleTitleCorrelation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma Cancer 94 1770–6 Occurrence Handle11920540 Occurrence Handle10.1002/cncr.10398

    Article  PubMed  Google Scholar 

  26. T Uenishi S Kubo K Hirohashi H Tanaka T Shuto T Yamamoto et al. (2003) ArticleTitleCytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer Br J Cancer 88 1894–9 Occurrence Handle12799633 Occurrence Handle1:STN:280:DC%2BD3szis1GntA%3D%3D Occurrence Handle10.1038/sj.bjc.6601026

    Article  PubMed  CAS  Google Scholar 

  27. T Kashihara A Ohki T Kobayashi T Sato H Nishizawa K Ogawa et al. (1998) ArticleTitleIntrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level J Gastroenterol 33 447–53 Occurrence Handle9658330 Occurrence Handle1:STN:280:DyaK1czit1CltA%3D%3D Occurrence Handle10.1007/s005350050112

    Article  PubMed  CAS  Google Scholar 

  28. InstitutionalAuthorNameLiver Cancer Study Group of Japan (1992) The general rule for the clinical and pathological study of primary liver cancer (in Japanese) 3rd ed Kanehara Tokyo 1–76

    Google Scholar 

  29. S Kubo S Nishiguchi K Hirohashi T Shuto T Kuroki S Minamitani et al. (1998) ArticleTitleClinical criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis Jpn J Cancer Res 89 419–26 Occurrence Handle9617348 Occurrence Handle1:CAS:528:DyaK1cXivFSntLg%3D

    PubMed  CAS  Google Scholar 

  30. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer (1994) ArticleTitleClassification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1513–20 Occurrence Handle8188183 Occurrence Handle1:STN:280:DyaK2c3ksFWisw%3D%3D Occurrence Handle10.1016/0270-9139(94)90250-X

    Article  PubMed  CAS  Google Scholar 

  31. RG Knodell KG Ishak WC Black TS Chen R Craig N Kaplowitz et al. (1981) ArticleTitleFormulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 431–5 Occurrence Handle7308988 Occurrence Handle1:STN:280:DyaL38%2FnsVagsA%3D%3D

    PubMed  CAS  Google Scholar 

  32. E Sabattini K Bisgaard S Ascani S Poggi M Piccioli C Ceccarelli et al. (1998) ArticleTitleThe En Vision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques J Clin Pathol 51 506–11 Occurrence Handle9797726 Occurrence Handle1:STN:280:DyaK1M%2FhsVClsg%3D%3D

    PubMed  CAS  Google Scholar 

  33. N Vyberg S Nielsen (1998) ArticleTitleDextran polymer conjugate two-step visualization system for immunohistochemistry. A comparison of En Vision+ with two three-step avidin biotin techniques Appl Immunohistochem Mol Morphol 6 3–10 Occurrence Handle1:CAS:528:DyaK1cXitlChtbk%3D Occurrence Handle10.1097/00022744-199803000-00002

    Article  CAS  Google Scholar 

  34. InstitutionalAuthorNameThe Liver Cancer Study Group of Japan (1987) ArticleTitlePrimary liver cancer in Japan. Sixth report Cancer 60 1400–11

    Google Scholar 

  35. T Uenishi K Hirohashi S Kubo T Yamamoto O Yamazaki H Kinoshita (2001) ArticleTitleClinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma Br J Surg 88 969–74 Occurrence Handle11442529 Occurrence Handle1:STN:280:DC%2BD3MzovVOktA%3D%3D Occurrence Handle10.1046/j.0007-1323.2001.01784.x

    Article  PubMed  CAS  Google Scholar 

  36. M Yamamoto K Takasaki T Otsubo H Katsuragawa S Katagiri (2001) ArticleTitleRecurrence after surgical resection of intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 8 154–7 Occurrence Handle11455472 Occurrence Handle1:STN:280:DC%2BD3MvgtFSntQ%3D%3D Occurrence Handle10.1007/s005340170039

    Article  PubMed  CAS  Google Scholar 

  37. Y Morimoto Y Tanaka T Ito M Nakahara H Nakaba T Nishida et al. (2003) ArticleTitleLong-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 432–40 Occurrence Handle14714164 Occurrence Handle10.1007/s00534-002-0842-3

    Article  PubMed  Google Scholar 

  38. K Inoue M Makuuchi T Takayama G Torzilli J Yamamoto K Shimada et al. (2000) ArticleTitleLong-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma Surgery 127 498–505 Occurrence Handle10819057 Occurrence Handle1:STN:280:DC%2BD3c3nvFShuw%3D%3D

    PubMed  CAS  Google Scholar 

  39. JR Madariaga S Iwatsuki S Todo RG Lee W Irish TE Starzl (1998) ArticleTitleLiver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases Am Surg 227 70–9 Occurrence Handle1:STN:280:DyaK1c7gsFymug%3D%3D

    CAS  Google Scholar 

  40. LE Harrison Y Fong DS Klimstra SY Zee LH Blumgart (1998) ArticleTitleSurgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma Br J Surg 85 1068–70 Occurrence Handle9717998 Occurrence Handle1:STN:280:DyaK1czot1Squg%3D%3D Occurrence Handle10.1046/j.1365-2168.1998.00796.x

    Article  PubMed  CAS  Google Scholar 

  41. T Maeda E Adachi K Kajiyama K Sugimachi M Tsuneyoshi (1995) ArticleTitleCombined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features Hum Pathol 26 956–64 Occurrence Handle7545644 Occurrence Handle1:STN:280:DyaK2Mvgt12msQ%3D%3D Occurrence Handle10.1016/0046-8177(95)90084-5

    Article  PubMed  CAS  Google Scholar 

  42. MJ Ligtenberg F Buijs HL Vos J Hilkens (1992) ArticleTitleSuppression of cellular aggregation by high levels of episialin Cancer Res 52 2318–24 Occurrence Handle1559234 Occurrence Handle1:CAS:528:DyaK38Xitlaqtbg%3D

    PubMed  CAS  Google Scholar 

  43. E van de Wiel-van KemenaDe MJ Ligtenberg AJ De Boer F Buijs HL Vos et al. (1993) ArticleTitleEpisialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction J Immunol 151 767–76 Occurrence Handle7687622 Occurrence Handle1:CAS:528:DyaK3sXmt1Cjur8%3D

    PubMed  CAS  Google Scholar 

  44. Y Makiguchi Y Hinoda K Imai (1996) ArticleTitleEffect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth Jpn J Cancer Res 87 505–11 Occurrence Handle8641988 Occurrence Handle1:CAS:528:DyaK28Xjt1Omsbw%3D

    PubMed  CAS  Google Scholar 

  45. J Wesseling SW van de Valk HL Vos A Sonnenberg Hilkens J. Episialin (1995) ArticleTitleMUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components J Cell Biol 129 255–65 Occurrence Handle7698991 Occurrence Handle1:CAS:528:DyaK2MXkslKqt7s%3D Occurrence Handle10.1083/jcb.129.1.255

    Article  PubMed  CAS  Google Scholar 

  46. J Wesseling SW van de Valk J Hilkens (1996) ArticleTitleA mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1 Mol Biol Cell 7 565–77 Occurrence Handle8730100 Occurrence Handle1:CAS:528:DyaK28Xit12qs70%3D

    PubMed  CAS  Google Scholar 

  47. J Hilkens MJ Ligtenberg HL Vos SL Litvinov (1992) ArticleTitleCell membrane-associated mucins and their adhesion-modulating property Trends Biochem Sci 17 359–63 Occurrence Handle1412714 Occurrence Handle1:CAS:528:DyaK38Xls1Kjs7s%3D Occurrence Handle10.1016/0968-0004(92)90315-Z

    Article  PubMed  CAS  Google Scholar 

  48. LB Tee Y Kirilak WH Huang PG Smith RH Morgan GC Yeoh (1996) ArticleTitleDual phenotypic expression of hepatocytes and bile ductular markers in developing and preneoplastic rat liver Carcinogenesis 17 251–9 Occurrence Handle8625446 Occurrence Handle1:CAS:528:DyaK28XhtFCnuro%3D

    PubMed  CAS  Google Scholar 

  49. S Sell HA Dunsford (1989) ArticleTitleEvidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma Am J Pathol 134 1347–63 Occurrence Handle2474256 Occurrence Handle1:STN:280:DyaL1Mzjtlyrtw%3D%3D

    PubMed  CAS  Google Scholar 

  50. L Libbrecht V Desmet B Van Damme T Roskams (2000) ArticleTitleThe immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells J Hepatol 33 76–84 Occurrence Handle10905589 Occurrence Handle1:STN:280:DC%2BD3M%2FktVKnsg%3D%3D Occurrence Handle10.1016/S0168-8278(00)80162-2

    Article  PubMed  CAS  Google Scholar 

  51. K Shirabe T Kanematsu T Matsumata E Adachi K Akazawa K Sugimachi (1991) ArticleTitleFactors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses Hepatology 14 802–5 Occurrence Handle1657754 Occurrence Handle1:STN:280:DyaK38%2FjvFGjsw%3D%3D

    PubMed  CAS  Google Scholar 

  52. J Belghiti Y Panis O Farges JP Benhamou F Fekete (1991) ArticleTitleIntrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis Am Surg 214 114–7 Occurrence Handle1:STN:280:DyaK3MzivVGqtA%3D%3D

    CAS  Google Scholar 

  53. SC Jwo JH Chiu GY Chau CC Loong WY Lui (1992) ArticleTitleRisk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection Hepatology 16 1367–71 Occurrence Handle1332922 Occurrence Handle1:STN:280:DyaK3s%2FnslWgsw%3D%3D

    PubMed  CAS  Google Scholar 

  54. N Nagasue M Uchida Y Makino Y Takemoto A Yamanoi T Hayashi et al. (1993) ArticleTitleIncidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma Gastroenterology 105 488–94 Occurrence Handle8392955 Occurrence Handle1:STN:280:DyaK3szivVSmsg%3D%3D

    PubMed  CAS  Google Scholar 

  55. S Kubo K Hirohashi H Tanaka T Tsukamoto T Shuto T Ikebe et al. (2000) ArticleTitleRisk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma World J Surg 24 1559–65 Occurrence Handle11193723 Occurrence Handle1:STN:280:DC%2BD3M3gtFKnsA%3D%3D Occurrence Handle10.1007/s002680010277

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan

    Tsuyoshi Ichikawa, Takahiro Uenishi, Hiromu Tanaka, Shigekazu Takemura, Masao Ogawa, Shogo Tanaka & Shoji Kubo

  2. Department of Surgery, Ishikiri-Seiki Hospital, Osaka, Japan

    Takatsugu Yamamoto

  3. Department of Cardiovascular Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan

    Shigefumi Suehiro

  4. Department of Graduate Medical Education, Osaka City University Graduate School of Medicine, Osaka, Japan

    Kazuhiro Hirohashi

Authors
  1. Tsuyoshi Ichikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takatsugu Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takahiro Uenishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiromu Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shigekazu Takemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masao Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shogo Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shigefumi Suehiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kazuhiro Hirohashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shoji Kubo
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Ichikawa, T., Yamamoto, T., Uenishi, T. et al. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 13, 245–251 (2006). https://doi.org/10.1007/s00534-005-1070-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-005-1070-4

Key words

Search

Navigation